Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRELD2 - Glucose effect on steroid receptor coactivator 1 deficient-A549 lung cancer epithelial cell line
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CRELD2 - Type 2 diabetes: pancreatic beta-cells
CRELD2 - Progerin expression in a hTERT-immortalized skin fibroblast cell line: time course
CRELD2 - Argyrin A effect on MCF7 breast cancer cells: time course
CRELD2 - Zinc effect on malignant and non-malignant prostate cell lines: time course
CRELD2 - Metastatic prostate cancer (HG-U95B)
CRELD2 - Endothelin-1 effect on fibroblasts
CRELD2 - Transforming growth factor-beta effect on normal ovarian fibroblast NOF151 cells
CRELD2 - Sjögren's syndrome: minor salivary glands
CRELD2 - Atherosclerotic left anterior descendent coronary artery: high scan
GEO DataSets Gene Chromosome neighbors Homologene neighbors
CRELD2 - Nodular lymphocyte-predominant Hodgkin lymphoma: lymphocytic and histiocytic cells
CRELD2 - Waldenstrom's macroglobulinemia: B lymphocytes and plasma cells
CRELD2 - Methyl-CpG-binding protein 2 binding disruption during neuronal maturation
CRELD2 - Various lung cancer cell lines
CRELD2 - Prostate cancer progression
CRELD2 - Multiple myeloma molecular classification
CRELD2 - Plasma cell dyscrasias
CRELD2 - Ethanol effect on lymphoblastoid cell lines from alcoholics
CRELD2 - Human epidermal growth factor receptor 2-positive breast cancer brain metastases
CRELD2 - LAMP3 depleted cell line response to interferon-alpha: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on